Concepedia

Runa Eta

RE

6

Publications

176

Citations

6

H-Index

2001

Active since

Affiliations

Zeria Pharmaceutical (Japan)(Current)

Runa Eta is an author at Zeria Pharmaceutical (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2001–2010

6

Publications

6

Acotiamide Hydrochloride (Z-338), a New Selective Acetylcholinesterase Inhibitor, Enhances Gastric Motility without Prolonging QT Interval in Dogs: Comparison with Cisapride, Itopride, and Mosapride

Yugo Matsunaga, Takao Tanaka, Koji Yoshinaga et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 65 citations

Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro

Daisuke Kawasaki, Yutaka Emori, Runa Eta et al. · Cancer Chemotherapy and Pharmacology · 2007 · 37 citations

, , +9

Effect of polaprezinc on taste disorders in zinc‐deficient rats

Hiroki Hamano, Koji Yoshinaga, Runa Eta et al. · BioFactors · 2006 · 36 citations

Pharmacological Evaluation of Analgesic Effects of the Cholecystokinin2 Receptor Antagonist Z-360 in Mouse Models of Formalin- and Cancer-Induced Pain

Koji Yoshinaga, Takayuki Horii, Hiroki Hamano et al. · Biological and Pharmaceutical Bulletin · 2010 · 15 citations · Full text

Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats

Hiroki Hamano, Koji Yoshinaga, Takao Tanaka et al. · Life Sciences · 2009 · 13 citations

, , +5

Rows per page

1–5 of 6